SCHEMBL4008329

SCHEMBL4008329

Brc1cccnc1Oc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 6/20 0.51
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 3/20 0.49
HTR1A P08908 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
MAPK8 P45983 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LTA4H P09960 1/20 0.42
TSHR P16473 1/20 0.42
ELANE P08246 1/20 0.42
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
DRD1 P21728 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3878940 0.85 PDE10A (0.43) PDE10ATDP1ALDH1A1KMT2AMEN1
SCHEMBL20406612 0.83 PDE10A (0.48) PDE10ATDP1ALDH1A1KMT2AMEN1
SCHEMBL580112 0.83 MEN1 (0.56) PDE10ATDP1ALDH1A1KMT2AMEN1
SCHEMBL31395507 0.83 PDE10A (0.51) PDE10ATDP1KMT2AMEN1LTA4H
SCHEMBL20406610 0.83 PDE10A (0.51) PDE10ATDP1KMT2AMEN1LTA4H
SCHEMBL20406238 0.83 PDE10A (0.48) PDE10ATDP1ALDH1A1KMT2AMEN1
SCHEMBL7910614 0.83 KMT2A (0.59) PDE10ATDP1ALDH1A1KMT2AMEN1
SCHEMBL2488534 0.83 RAB9A (0.56) PDE10AALDH1A1KMT2AMEN1CYP1A2
SCHEMBL15923259 0.83 LMNA (0.52) PDE10ATDP1ALDH1A1LTA4HPOLB
SCHEMBL31395515 0.83 PDE10A (0.53) PDE10AKMT2ACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353852-A1 COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE KINETA INC (US) 2025-11-20 US disclosed
EP-4444316-A1 COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE Kineta, Inc. (US) 2024-10-16 EP disclosed
WO-2023107557-A1 COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE Kineta, Inc. (US) 2023-06-15 WO disclosed
WO-2023107557-A1 COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE Kineta, Inc. (US) 2023-06-15 WO disclosed
CN-109843858-A Certain chemical entities, composition and method 润新生物公司 2019-06-04 CN disclosed
CN-109476632-A Tetrahydronaphthyridderivates pentanamide integrin antagonists 洛克菲勒大学 2019-03-15 CN disclosed
CN-109369654-A 1,3- bis- substituted-4-amino Pyrazolopyrimidines and its preparation method and application 山东大学 2019-02-22 CN disclosed
CN-107847765-A The piperidine derivative of 1,4 substitutions 赛福伦公司 2018-03-27 CN disclosed
WO-2009081259-A1 PHENOXY-PYRIDYL DERIVATIVES PFIZER INC. (US) 2009-07-02 WO disclosed
WO-2009081259-A1 PHENOXY-PYRIDYL DERIVATIVES PFIZER INC. (US) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353852-A1 COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE PIKFYVE, TARDBP, TDP1 PDE10A 2113/4885TDP1 3/4885ALDH1A1 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.